A Study Of IMM47 In Subjects With Advanced Solid Tumors

NCT05985083 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Oncology

Interventions

DRUG: IMM47

Sponsor

ImmuneOnco Biopharmaceuticals (Shanghai) Inc.

Collaborators

[object Object]